Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments
From MaRDI portal
Publication:6572271
DOI10.1002/BIMJ.202000326zbMATH Open1541.62299MaRDI QIDQ6572271FDOQ6572271
Authors: Roland G. Gera, Tim Friede 
Publication date: 15 July 2024
Published in: Biometrical Journal (Search for Journal in Brave)
multiple testingsample size calculation\(p\)-value combinationsample size reestimationsubpopulation analysis
Cites Work
- Computation of multivariate normal and \(t\) probabilities
- On closed testing procedures with special reference to ordered analysis of variance
- Combining Independent Tests of Significance
- Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts
- Adaptive Sample Size Calculations in Group Sequential Trials
- Sample size recalculation in internal pilot study designs: a review
- Statistics applied to clinical trials. With the help from Toine F. Cleophas, Eugene P. Cleophas, and Henny I. Cleophas-Allers.
- Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations
- Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: methods, simulation model and their implementation in R
- A conditional error function approach for adaptive enrichment designs with continuous endpoints
- Level of evidence for promising subgroup findings: the case of trends and multiple subgroups
This page was built for publication: Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6572271)
